Cholesterol-lowering medication
1 paper3 findings
- 1 lab in 1 country
- Humans1
Outcomes
3Visual attention
downin humans1
1 study
Visual attention
downin humans1
Cholesterol-lowering medication impairs visual attention in humans (0.393, 95%CI (0.120, 0.665)).
“and a steeper decline of visual attention[0.393,(0.120,0.665)].”
Humansurban population1 yearn = 518
AAIC 2025 abstract23 Dec 2025
Memory
upin humans1
1 study
Memory
upin humans1
Cholesterol-lowering medication improves memory in humans (immediate recall -0.369 (-0.642, -0.097), delayed recall -0.439 (-0.711, -0.166)).
“and memory (immediate [‐0.369,(‐0.642,‐0.097)] and delayed [‐0.439, (‐0.711, ‐0.166)] recall) functioning”
Humansurban population1 yearn = 518
AAIC 2025 abstract23 Dec 2025
Language function
upin humans1
1 study
Language function
upin humans1
Cholesterol-lowering medication improves language function in humans (-0.378, 95%CI (-0.649, -0.106)).
“the use of cholesterol‐lowering medication was associated with a slower decline in language[‐0.378,(‐0.649,‐0.106)]”
Humansurban population1 yearn = 518
AAIC 2025 abstract23 Dec 2025
Latest
1 in 12 monthsAAIC 2025 Abstract
Association between serum lipid dysregulation, management, and cognitive decline in rural and urban Southern Indian population
Cohort study of 766 peoplePopulations